SCHEMBL19180617

SCHEMBL19180617

O=P(O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(O)nc(O)nc32)C[C@@H]1O

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.57
▸ NT5E P21589 1/20 0.55
▸ P2RY6 Q15077 2/20 0.52
▸ P2RY2 P41231 1/20 0.52
▸ P2RY4 P51582 1/20 0.52
▸ ENPP1 P22413 5/20 0.51
▸ P2RY1 P47900 4/20 0.51
▸ P2RX3 P56373 3/20 0.48
▸ P2RX2 Q9UBL9 2/20 0.48
▸ P2RY12 Q9H244 1/20 0.48
▸ P2RX1 P51575 2/20 0.47
▸ P2RY11 Q96G91 1/20 0.47
▸ P2RX4 Q99571 1/20 0.47
▸ DTYMK P23919 2/20 0.46
▸ RNASEL Q05823 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1069101 0.99 POLB (0.56) POLBNT5EP2RY6P2RY2P2RY4
SCHEMBL2883759 0.92 NT5E (0.58) POLBNT5EENPP1P2RY1
SCHEMBL29642033 0.90 NT5E (0.64) POLBNT5EP2RY6P2RY2P2RY4
SCHEMBL15573313 0.90 NT5E (0.64) POLBNT5EP2RY6P2RY2P2RY4
SCHEMBL2508660 0.88 POLB (0.66) POLBNT5EP2RY2ENPP1P2RY1
SCHEMBL2508646 0.88 POLB (0.66) POLBNT5EP2RY2ENPP1P2RY1
Triphosphate SCHEMBL28101757 0.88 POLB (0.61) POLBNT5EP2RY6P2RY2P2RY4
SCHEMBL29465233 0.87 POLB (0.65) POLBP2RY2ENPP1P2RY1P2RX3
SCHEMBL245486 0.87 POLB (0.65) POLBP2RY2ENPP1P2RY1P2RX3
SCHEMBL1763078 0.87 POLB (0.65) POLBP2RY2ENPP1P2RY1P2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3199639-B1 NOVEL MEASUREMENT METHOD USING KINASE, AND COMPOSITION ASAHI KASEI PHARMA CORP (JP) 2020-12-30 — — EP disclosed
US-10472665-B2 Measuring method and composition using kinase ASAHI KASEI PHARMA CORPORATION (JP) 2019-11-12 — — US disclosed
US-20170306389-A1 NOVEL MEASURING METHOD AND COMPOSITION USING KINASE ASAHI KASEI PHARMA CORPORATION (JP) 2017-10-26 — — US disclosed
EP-3199639-A1 NOVEL MEASUREMENT METHOD USING KINASE, AND COMPOSITION Asahi Kasei Pharma Corporation (JP) 2017-08-02 — — EP disclosed
Send feedback